Eton Pharmaceuticals Q1 2026 Earnings EPS Miss Triggers Stock Decline Asana Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue BBT Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Quarter MPWR Q1 2026 Earnings EPS Exceeds Expectations Amid Strong Demand Income Opportunity Realty Investors Inc Q4 2024 Earnings Positive EPS Amid Limited Disclosure LEN Q1 2026 Earnings EPS Misses Estimates as Housing Market Pressures Persist CSAI Q4 2025 Earnings Loss Widens Amid Transition Stock Falls 24 UFCS Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Discipline BDX Q1 2026 Earnings EPS Surpasses Estimates with 347 Beat CRSP Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline STRR Q1 2026 Earnings Significant EPS Miss But Stock Gains 342